Nasacort AQ moves step closer to US switch

1 August 2013 - Deborah Wilkes

Archived

Sanofi's Nasacort AQ (triamcinolone acetonide) nasal spray has moved a step closer to a switch from prescription to OTC status in the US.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: